Prolactin: Does it exert an up-modulation of the immune response in Trypanosoma cruzi-infected rats?

Veterinary Parasitology

Volumn 181, Issue 2-4, 2011, Pages 139-145

  Filipin, Marina Del Vecchio ^a   Brazão, Vânia ^a   Santello, Fabricia Helena ^a   Caetano, Leony Cristina ^a   Toldo, Míriam Paula Alonso ^a   Do Prado, José Clóvis ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Lymphocytes; Macrophages; Nitrite; Prolactin; Trypanosoma cruzi

Indexed keywords

NITRIC OXIDE; PROLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELLULAR IMMUNITY; CHAGAS DISEASE; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PARASITEMIA; RAT; T LYMPHOCYTE; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; UPREGULATION;

ANIMALS; CELL PROLIFERATION; CHAGAS DISEASE; CONCANAVALIN A; FLOW CYTOMETRY; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; NITRIC OXIDE; PARASITEMIA; PROLACTIN; RATS; RATS, WISTAR; T-LYMPHOCYTE SUBSETS; THYMOCYTES; TRYPANOSOMA CRUZI; UP-REGULATION;

RATTUS; TRYPANOSOMA CRUZI;

EID: 80052523626     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2011.04.008     Document Type: Article

References (57)

1. Abrahamsohn I.A., Coffman R.L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 1995, 155:3955-3963.
2. Adams L.B., Hibbs, Taintor R.R., Krahenbuhl J.L. Microbistatic effect of murine-activated macrophages for Toxoplasma gondii role for synthesis of inorganic nitrogen oxides from l-arginine. J. Immunol. 1990, 144:2725-2729.
3. Benedetto N., Folgore A., Galdiero M., Meli R., Di Carlo R. Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis. Pathol. Biol. 1995, 43:395-400.
4. Brazão V., Caetano L.C., Filipin M.Del Vecchio, Toldo M.Paula Alonso, Caetano L.N., do Prado J.C. Zinc supplementation increases resistance to experimental infection by Trypanosoma cruzi. Vet. Parasitol. 2008, 154:32-37.
5. Brener Z. The behavior of slender and stout forms of Trypanosoma cruzi in the blood-stream of normal and immune mice. Ann. Trop. Med. Parasitol. 1969, 63:215-220.
6. Biswas R., Chattopadhyay U. Altered prolactin response of lymphocytes of tumor bearing mice. Int. J. Cancer 1992, 50:93-98.
7. Biswas R., Roy T., Chattopadhyay U. Prolactin induced reversal of glucocorticoid mediated apoptosis of immature cortical thymocytes is abrogated by induction of tumor. J. Neuroimmunol. 2006, 171:120-134.
8. Bolander F.F. The role of nitric oxide in the biological activity of prolactin in the mouse mammary gland. Mol. Cell Endocrinol. 2001, 174:91-98.
9. Bolander F.F. Prolactin activation of mammary nitric oxide synthase: molecular mechanisms. J. Mol. Endocrinol. 2002, 28:45-51.
10. Bole-Feysot C., Goffin V., Edery M., Binart N., Kelly P.A. Prolactin (PRL) and its receptor: actions signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 1998, 19:225-268.
11. Caetano L.C., Santello F.H., Filipin M.Del Vecchio, Brazão V., Caetano L.N., Toldo M.P., Caldeira J.C., do Prado J.C. Trypanosoma cruzi: dehydroepiandrosterone (DHEA) and immune response during the chronic phase of the experimental Chagas' disease. Vet. Parasitol. 2009, 163:27-32.
12. Carreño P.C., Jiménez E., Sacedón R., Vicente A., Zapata A.G. Prolactin stimulates maturation and function of rat thymic dendritic cells. J. Neuroimmunol. 2004, 153:83-90.
13. Carreño P.C., Sacedón R., Jiménez E., Vicente A., Zapata A.G. Prolactin affects both survival and differentiation of T-cell progenitors. J. Neuroimmunol. 2005, 160:135-145.
14. Clevenger C.V., Altmann S.W., Prystowsky M.B. Requirement of nuclear prolactin for interleukin-2-stimulated proliferation of T lymphocytes. Science 1991, 253:77-79.
15. Clevenger C.V., Freier D.O., Kline J.B. Prolactin receptors signal transduction in cell of the immune system. J. Endocrinol. 1998, 157:187-197.
16. Corrêa-de-Santana E., Paez-Pereda M., Theodoropoulou M., Renner U., Stalla J., Stalla G.K., Savino W. Modulation of growth hormone and prolactin secretion in Trypanosoma cruzi-infected mammosomatotrophic cells. Neuroimmunomodulation 2009, 16:208-212.
17. De Mello-Coelho V., Savino W., Postel-Vinay M.C., Dardenne M. Role of prolactin and growth hormone on thymus physiology. Dev. Immunol. 1998, 6:317-323.
18. Di Carlo R., Meli R., Galdiero M., Nuzzo I., Bentivoglio C., Carratelli C.R. Prolactin protection against lethal effects of Salmonella typhimurium. Life Sci. 1993, 53:981-989.
19. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 1988, 141:2407.
20. Dorshkind K., Horseman N.D. The roles of prolactin, growth hormone, insulin like growth factor-1 and thyroid hormones in lymphocyte development and function. Insights from genetic models of hormone and hormone receptor deficiency. Endocr. Rev. 2000, 21:292-312.
21. Dorshkind K., Horseman N.D. Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays 2001, 23:288-294.
22. Dost C.K., Saraiva J., Zentgraf U., Monesi N., Engels W., Albuquerque S. Is nitric oxide involved in the tolerance of Calomys callosus as a reservoir host towards Trypanosoma cruzi infection?. J. Infect. 2006, 52:49-55.
23. Escobedo G., Roberts C.W., Carrero J.C., Morales-Montor J. Parasite regulation by host hormones: an old mechanism of host exploitation?. Trends Parasitol. 2005, 12:588-593.
24. Filipin M.Del V., Brazão V., Caetano L.C., Santello F.H., Toldo M.P., Caetano L.N., do Prado J.C. Trypanosoma cruzi: orchiectomy and dehydroepiandrosterone therapy in infected rats. Exp. Parasitol. 2008, 120:249-254.
25. Gieni R.S., Li Y., HayGlass K.T. Comparison of [3H] thymidine incorporation with MTT and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. J. Immunol. Methods 1995, 187:85-93.
26. Kelley K.W., Dantzer R. Growth hormone and prolactin as natural antagonists of glucocorticoids in immunoregulation. Stress and Immunity 1991, 433-452. CRC Press, Boca Raton, FL. N. Plotnikoff, A. Murgo, R. Faith, J. Wybran (Eds.).
27. Kierszenbaum F., Sztein M.B. Parasitic Infections and the Immune System 1994, 53. Academic Press, San Diego. F. Kierszenbaum (Ed.).
28. Kooijman R., Hooghe-Peters E.L., Hooghe R. Prolactin, growth hormone, and insulin-like growth factor-I in the immune system. Adv. Immunol. 1996, 63:377-454.
29. Kooijman R., Gerlo S., Coppens A., Hooghe-Peters E.L. Growth hormone and prolactin expression in the immune system. Ann. NY Acad. Sci. 2000, 917:534-540.
30. Liew F.Y., Yun L., Milott S. Tumor necrosis factor-a with IFN-y in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 1990, 145:4306-4310.
31. Majumder B., Biswas R., Chattopadhyay U. Prolactin regulates antitumor immune response through induction of tumoricidal macrophages and release of IL-12. Int. J. Cancer 2002, 97:493-500.
32. Matera L., Cesano A., Bellone G., Oberholtzer E. Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes. Brain Behav. Immun. 1992, 6:409-417.
33. Matera L. Action of pituitary and lymphocyte prolactin. Neuroimmunomodulation 1997, 4:171-180.
34. Matera L., Mori M., Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus 2001, 10:728-734.
35. Murray H.W., Teitelbaum R.F. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 1992, 165:513-517.
36. Oberbeck R., Schmitz D., Wilsenack K., Schüler M., Biskup C., Schedlowski M., Nast-Kolb D., Exton M.S. Prolactin modulates survival and cellular immune functions in septic mice. J. Surg. Res. 2003, 113:248-256.
37. Pascutti M.F., Bottasso O.A., Hourquescos M.C., Wietzerbin J., Revelli S. Age-related increase in resistance to acute Trypanosoma cruzi infection in rats is associated with an appropriate antibody response. Scand. J. Immunol. 2003, 58:173-179.
38. Pearson R.D. Chagas cardiomyopathy (Trypanosoma cruzi): does prolactin play a role?. Cytokine Growth Factor Rev. 2007, 18:209.
39. Pérez A.R., Roggero E., Nicora A., Palazzi J., Besedovsky H.O., del Rey A., Bottasso O.A. Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav. Immun. 2007, 21:890-900.
40. Quintanar J.L., Salinas E., Guerrero R., Gómez R., Vidal S., Aranda J., Clapp C. Prolactin-like hormone in the nematode Trichinella spiralis larvae. Exp. Parasitol. 2007, 116:137-141.
41. Roggero E., Pérez A.R., Tamae-Kakazu M., Piazzon I., Nepomnaschy I., Besedovsky H.O., Bottasso O.A., Del Rey A. Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J. Endocrinol. 2006, 190:495-503.
42. Ryníková A., Koppel J., Kuchár S., Cikos S., Mozes S. Effects of ovine prolactin in infant rats. Exp. Clin. Endocrinol. 1988, 92:241-244.
43. Sabharwal P., Glaser R., Lafuse W., Varma S., Liu Q., Arkins S., Kooijman R., Kutz L., Kelley K.W., Malarkey W.B. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:7713-7716.
44. Sacks D., Sher A. Evasion of innate immunity by parasitic protozoa. Nat. Immunol. 2002, 3:1041-1047.
45. Santello F.H., Frare E.O., dos Santos C.D., Toldo M.P., Kawasse L.M., Zucoloto S., do Prado J.C. Melatonin treatment reduces the severity of experimental Trypanosoma cruzi infection. J. Pineal Res. 2007, 42:359-363.
46. Santos C.D., Toldo M.P., Santello F.H., Filipin M.Del V., Brazão V., do Prado J.C. Dehydroepiandrosterone increases resistance to experimental infection by Trypanosoma cruzi. Vet. Parasitol. 2008, 153:238-243.
47. Silva L.H.P., Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin. Biol. 1953, 20:191-201.
48. Silva J.S., Machado F.S., Martins G.A. The role of nitric oxide in the pathogenesis of Chagas disease. Front. Biosci. 2003, 8:314-325.
49. Smith P.E. The effect of hypophysectomy upon the involution of the thymus in the rat. Anal. Rec. 1930, 47:119-126.
50. Tarleton R.L. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 1990, 144:717-724.
51. Tarleton R.L., Sun J., Zhang L., Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect. Immun. 1994, 62:1820-1829.
52. Tripathi A., Sodhi A. Production of nitric oxide by murine peritoneal macrophages in vitro on treatment with prolactin and growth hormone: involvement of protein tyrosine kinases, Ca++, and MAP kinase signal transduction pathways. Mol. Immunol. 2007, 44:3185-3194.
53. Umekita L.F., Mota I. How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?. Braz. J. Med. Biol. Res. 2000, 33:253-258.
54. Vespa G.N., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 1994, 62:5177-5182.
55. Yu-Lee L.Y. Molecular actions of prolactin in the immune system. Proc. Soc. Exp. Biol. Med. 1997, 215:35-52.
56. Yu-Lee L.Y. Prolactin modulation of immune and inflammatory responses. Recent Prog. Horm. Res. 2002, 57:435-455.
57. Zellweger R., Zhu X.H., Wichmann M.W., Ayala A., DeMaso C.M., Chaudry I.H. Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J. Immunol. 1996, 157.